Corticosteroid Withdrawal Management

Definition and Clinical Presentation

Prednisone withdrawal syndrome manifests as a constellation of symptoms that can mimic the underlying disease being treated or present as signs of adrenal insufficiency when corticosteroids are rapidly reduced or stopped 1
Common symptoms include weakness, fatigue, loss of appetite, weight loss, nausea, vomiting, diarrhea, abdominal pain, myalgia, arthralgia, and malaise 1

Higher doses of corticosteroids (particularly >10 mg prednisone daily) increase the likelihood and severity of withdrawal symptoms 2

Gradual tapering of corticosteroids is essential to prevent withdrawal syndrome, with dose reductions of approximately 2.5 mg per month until the lowest effective dose is reached 3, 4
For patients on long-term therapy who have relapsed after previous withdrawal attempts, low-dose prednisone maintenance using the lowest dose possible (median 7.5 mg daily) to prevent symptoms and maintain serum aminotransferase levels below 5-fold normal is recommended 3, 5
Indefinite azathioprine maintenance, substituting azathioprine (2 mg/kg daily) for prednisone after induction of remission, then gradually withdrawing prednisone, is also recommended 3, 5
All patients receiving corticosteroids should receive calcium (800-1000 mg/day) and vitamin D (800 IU/day) supplementation to prevent osteoporosis 1
Close monitoring during and after tapering is essential, with laboratory tests performed frequently during withdrawal and for at least 3 months after termination of therapy 6, 7

Patients with multiple relapses after withdrawal have higher risks of disease progression and adverse outcomes, warranting more careful management 3
Children may require more individualized tapering schedules, as they often need longer treatment periods and have higher relapse rates (60-80%) after drug withdrawal 6
With proper management, side effects associated with earlier conventional treatments improve or disappear in 85% of patients maintained on appropriate withdrawal protocols 5

Monitoring specific disease markers (such as serum aminotransferase levels in autoimmune hepatitis) can help differentiate between withdrawal syndrome and disease relapse 7